← Leaderboards
Jacqueline Suen Garcia
Dana-Farber Cancer Inst
$1,292,805
Attributed
$1,292,805
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $258.6K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,292,805 · 1
By mechanism
K08$1,292,805 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Anthony G Letai$22,380,537
- Alejandro Gutierrez$7,788,333
- Alex Kentsis$10,070,317
- Pavan Bachireddy$1,087,640
- Alan David D'andrea$28,094,196
Others in their field
Other Emerging Leaders on “Conditioning”
- Chanza Baytop · Westat, Inc.$271,217,917
- Laura Ferrarese · Association Of Universities For Research In Astronomy, Inc.$47,742,424
- Julie Brisset · The University Of Central Florida Board Of Trustees$41,275,036
- Ashlee Fitch · Steelworker Charitable/Educational Org$21,025,408
- Greg Westergaard · Alpha Genesis Inc$19,405,907
- Niels Kuster · It'Is Foundation$18,600,051
Research focus
ConditioningAcute Myeloid Leukemia CellClinical InvestigatorCombined Modality TherapyApoptoticAreaAcademic SupportAcute Myelocytic LeukemiaClinical TrialsClinical TranslationBh3 PeptideBiologicalBiologyBloodAllogenicBusulfanCareerCareer DevelopmentCellsApoptosisBh3 DomainClinical ResearchChemotherapyCytochrome C
Grant awards (5)
Enhancing Venetoclax Activity in Chemoresistant Acute Myeloid Leukemia$258,561
K08 · FY2024 · CA · contact PI
Enhancing Venetoclax Activity in Chemoresistant Acute Myeloid Leukemia$258,561
K08 · FY2023 · CA · contact PI
Enhancing Venetoclax Activity in Chemoresistant Acute Myeloid Leukemia$258,561
K08 · FY2022 · CA · contact PI
Enhancing Venetoclax Activity in Chemoresistant Acute Myeloid Leukemia$258,561
K08 · FY2021 · CA · contact PI
Enhancing Venetoclax Activity in Chemoresistant Acute Myeloid Leukemia$258,561
K08 · FY2020 · CA · contact PI